Archives
o2h Ventures backed Neurofenix raises $7 Million to transform stroke and brain injury recovery 6 September, 2022
Funding boost for spin-out developing new medicines for life-threatening diseases 29 July, 2022
o2h Ventures makes an SEIS investment into CardiaTec 6 July, 2022
o2h Ventures backed Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer 14 June, 2022
The “o2h human health KI EIS fund” makes an investment into Neurocentrx 12 May, 2022
The “o2h human health SEIS fund” makes an investment into Neucruit 18 February, 2022
o2h Ventures makes a follow-on investment into Oxford Drug Design 18 February, 2022
o2h Ventures makes an investment into Xploro from “the o2h human health SEIS fund” 16 February, 2022
In4Derm raises £1.6m pre-Series A funding to support its growing pipeline of first-in-class anti-inflammatory and orphan disease therapeutics 3 November, 2021